Navigation Links
Astellas Expands Leadership Team With Senior Vice President of Corporate Strategy and Government Affairs
Date:8/15/2011

DEERFIELD, Ill., Aug. 15, 2011 /PRNewswire/ -- Astellas US, LLC ("Astellas") recently named Percival Barretto-Ko as Senior Vice President, Corporate Strategy and Government Affairs, a new position added to the company's leadership team.  Reporting to President and CEO Masao Yoshida, Barretto-Ko will be responsible for corporate planning, business development, government policy and external affairs and state government affairs.

"This realignment brings key strategic functions closer together at the corporate level," Yoshida said.  "Percival has an outstanding track record both in the pharmaceutical industry and at Astellas' European operations.  He will be a great addition to our senior management team."

Barretto-Ko will move from the position of executive director, corporate strategy and communications at Astellas Pharma Europe Ltd.  While there, he led the global launch of Astellas' new pipeline drug, Advagraf® (tacrolimus prolonged release) in 20 countries. He was promoted to lead the organization's corporate planning function and ultimately directed corporate strategy, corporate planning, corporate communications, crisis management and corporate social responsibility. Prior to joining Astellas, he held increasingly more senior marketing and sales positions with the Roche Group in the United States and United Kingdom. Barretto-Ko earned his undergraduate degree from Cornell University, an MBA from Yale School of Management, and an MS from MIT Sloan School of Management, where he recently served as a Sloan Fellow for Innovation and Global Leadership.

About Astellas

Astellas US LLC, located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader
'/>"/>

SOURCE Astellas US, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Astellas Announces Vice President of Sales and Marketing for U.S. Oncology Franchise
2. Optimer Pharmaceuticals and Astellas Announce Collaboration to Commercialize Fidaxomicin for Clostridium difficile infection (CDI) in Europe and Certain Other Countries in Middle East, Africa and CIS
3. Astellas to Review Strategic Business Alternatives for Prosidion Subsidiary
4. Reportlinker Adds Astellas Pharma Inc.: PharmaVitae Profile
5. Astellas Announces Retirement of Donald Rice and Appointment of Sef Kurstjens as CEO and President of Agensys, Inc.
6. Although NeurogesX/Astellass Qutenza is Only Approved for Postherpetic Neuralgia, Surveyed U.S. Physicians are Likely to Prescribe It for All Neuropathic Pain Types
7. Astellas Mobilizes 1,300+ Employees in the Americas to Participate in First Annual Changing Tomorrow Day
8. Astellas Awards Scholarships to 12 Transplant Recipients and Donors Who Embody Hope, Courage and Achievement
9. Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
10. Astellas Announces Successful Completion of Initial Tender Offer for Shares of OSI and Announces Subsequent Offer Period
11. Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals 2010 Annual Stockholders Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... --  Hospira, Inc. (NYSE: HSP ), ... leading provider of injectable drugs and infusion technologies, ... biosimilarity of its proposed biosimilar, Epoetin Hospira, with ... approved name of RETACRIT™, compared to the reference ... were presented at the National Kidney Foundation (NKF) ...
(Date:3/27/2015)... , March 27, 2015 ... 2015" therapeutic market research report of 52 pages ... online business intelligence library. The report ... on the therapeutic development for Visceral Pain, complete ... by drug target, mechanism of action (MoA), route ...
(Date:3/27/2015)... 2015  WebMD Health Corp. (NASDAQ: ... information, today announced an exclusive White House ... Plan for Combating Antibiotic-Resistant Bacteria . During ... and importance of addressing antibiotic-resistant bacteria and ... The WebMD interview, available online ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3
... Schering-Plough,Corporation (NYSE: SGP ) and The ... of Baltimore today announced results of the ... Eptifibatide to,Arrest the Reactivity of Platelets) study, ... IIIa inhibitor, significantly inhibited,platelet aggregation when added ...
... Immtech Pharmaceuticals,Inc. (Amex: IMM ) today ... a,scientific consortium led by the University of North ... The Bill & Melinda Gates Foundation,(the "Gates Foundation"), ... and leishmania. This grant is part of the ...
Cached Medicine Technology:Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 2Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 3Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 4Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 5Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 2Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 3
(Date:3/29/2015)... 29, 2015 The culmination of one of ... when the Final Four invades Lucas Oil Stadium ... been one filled with excitement, buzzer-beaters, and of course, upsets. ... superstars have been made, and future professional products have been ... to the four teams that advanced through their regional bracket ...
(Date:3/29/2015)... Youth Villages will participate in a partnership ... the feasibility of implementing a Pay for Success model ... their families. , Third Sector Capital Partners Inc. ran ... provided technical assistance throughout 2015 toward a Pay for ... awardees chosen by Third Sector. The organization’s work with ...
(Date:3/28/2015)... Coffee could not only perk you up in the ... researchers have found. , They found that those who drank ... Antioxidants fight gum disease. Does coffee, then, help fight gum ... M. Goldman School of Dental Medicine explored in a ... Journal of Periodontology. , “This is the first long-term study ...
(Date:3/28/2015)... New York, New York (PRWEB) March 28, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) involving devices manufactured by C.R. ... multidistrict litigation underway in U.S. District Court, Southern ... Jeffrey S. Grand, is serving on the Plaintiffs’ ... March 24th, the Court has granted certain defendants ...
(Date:3/28/2015)... Centurion Service Group will be hosting a live on-site and ... Las Vegas warehouse, located at 4606 Andrews St. Suite 3, ... equipment from hospitals and surgery centers from around the United ... Buyers will find items of all types including anesthesia, endoscopy, ... Erik Tivin, CEO of Centurion. , Among the sale’s ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 Final Four Tickets: Ticket Down Slashes Kentucky Wildcats and Wisconsin Badgers Final Four Tickets at Lucas Oil Stadium and Issues Valuable Promo Code 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 4Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Medical Equipment Auction to Take Place in North Las Vegas 2
... Bethesda, MD (March 1, 2009) Even in the ... need colorectal cancer screening receive the life-saving test. Those ... not include colorectal cancer screenings are even less likely ... the American Gastroenterological Association (AGA) is working to raise ...
... eDiets.com meal delivery offering to over 30,000 MembersNew ... Third Partnership within the new Fitness Industry Sales ... DIET ), and Diversified Health & ... work together to promote eDiets, award-winning, fresh-prepared diet ...
... for Net Operating Income and Year-End Cash- Achieves 2008 ... Conference Call Webcast Wednesday, February 25, 8:30 a.m. EST ... 25 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... highlights. Isis exceeded its 2008 financial guidance by ...
... Value under the Current Board and Management TeamDiscloses Details ... StockholdersCINCINNATI, Feb. 25 The ... filed presentations with the Securities and Exchange Commission in ... to replace the existing Board of Directors of LCA-Vision, ...
... SOUTH SAN FRANCISCO, Calif., Feb. 25 Proteolix, Inc., ... therapeutics that target protein degradation pathways in cancer and ... Scarlett, M.D., to the position of President and Chief ... of experience in drug development and commercialization to his ...
... 25 With the economy taking a nose dive,Americans ... travel to even medical,treatments. Both healthcare and dental care ... to a recent survey by Cigna, a leading provider ... care of their health,because of the economy. In ...
Cached Medicine News:Health News:Economy could reduce colorectal cancer screening rate 2Health News:eDiets.com(R) and Diversified Health & Fitness Announce New Strategic Marketing Partnership 2Health News:eDiets.com(R) and Diversified Health & Fitness Announce New Strategic Marketing Partnership 3Health News:eDiets.com(R) and Diversified Health & Fitness Announce New Strategic Marketing Partnership 4Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 2Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 3Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 4Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 5Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 6Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 7Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 8Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 9Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 10Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 11Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 12Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 13Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 14Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 15Health News:The LCA-Vision Full Value Committee Files Detailed Presentations 2Health News:The LCA-Vision Full Value Committee Files Detailed Presentations 3Health News:Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO 2Health News:Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO 3Health News:Put Your Money Where Your Mouth Is - Brush Up on Your Oral Health Today for a Healthier Tomorrow 2
... The Venus-i™ Laser System is a new, ... system with applications in dermatology, cosmetic and ... An ideal laser for skin resurfacing, it ... powerful, Erbium:YAG lasers on the market. It ...
... biolitecs sophisticated Ceralas D15/810 diode laser is ... ideal for many soft tissue applications. With ... D15/810 features a flexible fiber optic delivery ... irrigated or dry environments alike.,Compact and portable, ...
... D 980 nm diode laser provides controlled ... for most surgical procedures. Unlike other ... without collateral tissue damage or charring. ... instantly and seals small blood vessels ...
... The TonoPach is a device intended for ... IOP remains the single most important metric ... However, as discovered in a large, ... study published in mid-2002, the patients central ...
Medicine Products: